BE826568A - Procede de preparation de vaccins vivants contre la varicelle - Google Patents

Procede de preparation de vaccins vivants contre la varicelle

Info

Publication number
BE826568A
BE826568A BE2054201A BE2054201A BE826568A BE 826568 A BE826568 A BE 826568A BE 2054201 A BE2054201 A BE 2054201A BE 2054201 A BE2054201 A BE 2054201A BE 826568 A BE826568 A BE 826568A
Authority
BE
Belgium
Prior art keywords
vaccines against
live vaccines
preparing live
against chickenpox
chickenpox
Prior art date
Application number
BE2054201A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE826568A publication Critical patent/BE826568A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE2054201A 1974-03-12 1975-03-12 Procede de preparation de vaccins vivants contre la varicelle BE826568A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2931874A JPS5341202B2 (enExample) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
BE826568A true BE826568A (fr) 1975-09-12

Family

ID=12272859

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2054201A BE826568A (fr) 1974-03-12 1975-03-12 Procede de preparation de vaccins vivants contre la varicelle

Country Status (5)

Country Link
US (1) US3985615A (enExample)
JP (1) JPS5341202B2 (enExample)
BE (1) BE826568A (enExample)
FR (1) FR2263786B1 (enExample)
GB (1) GB1457382A (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
NZ220645A (en) * 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
IE61575B1 (en) * 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
HU220080B (hu) * 1992-06-04 2001-10-28 Merck And Co. Inc. Eljárás gyengített Varicella zoster vírus vakcina előállítására
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
JP4562812B2 (ja) * 1992-07-17 2010-10-13 メルク・シャープ・エンド・ドーム・コーポレイション 帯状疱疹の予防または水痘関連ヘルペス後神経痛の緩和方法
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
WO1997043420A1 (en) * 1996-05-15 1997-11-20 The Research Foundation For Microbial Diseases Of Osaka University Method for identifying attenuated chickenpox virus oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
GB9804632D0 (en) 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
CA2326699C (en) * 1999-02-25 2009-11-24 The Research Foundation For Microbial Diseases Of Osaka University Gene 62 of oka vaccine virus and method for identifying virus strain for live attenuated vaccine virus using the gene 62
US6528066B1 (en) * 1999-09-14 2003-03-04 University Of Iowa Research Foundation Variant varicella-zoster viruses and methods of use
WO2004042031A2 (en) * 2002-11-05 2004-05-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Safer attenuated virus vaccines with missing or diminished latency of infection
US8916175B2 (en) * 2004-06-29 2014-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
US10166285B2 (en) 2006-11-09 2019-01-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Recombinant virus with diminished latency and methods of using same
WO2008059959A1 (en) 2006-11-17 2008-05-22 The Research Foundation For Microbial Diseases Of Osaka University Nerve elongation promoter and elongation inhibitor
CN101967466A (zh) * 2009-07-28 2011-02-09 新泽西医学院 Orf7缺陷型水痘病毒株、含有该毒株的疫苗及其应用
UA112970C2 (uk) 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
EP2686423A4 (en) 2011-03-14 2015-01-28 Nat Res Council Canada METHOD FOR PRODUCING VIRUSES IN CELLS
US10232035B2 (en) 2012-09-14 2019-03-19 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes virus and use thereof in vaccines
SG11201803594TA (en) 2015-11-06 2018-05-30 Adjuvance Technologies Inc Triterpene saponin analogues

Also Published As

Publication number Publication date
GB1457382A (en) 1976-12-01
FR2263786A1 (enExample) 1975-10-10
JPS50123817A (enExample) 1975-09-29
JPS5341202B2 (enExample) 1978-11-01
US3985615A (en) 1976-10-12
FR2263786B1 (enExample) 1978-12-01

Similar Documents

Publication Publication Date Title
BE826568A (fr) Procede de preparation de vaccins vivants contre la varicelle
BE797300A (fr) Procede de preparation de vaccins adsorbes
BE858992A (fr) Procede de preparation de vaccins
FR2295010A1 (fr) Procede de preparation de methacrylate
BE823677A (fr) Procede de preparation de thiophosphates de dialkyle
FR2335235A1 (fr) Procede de preparation de substances anti-tumorales
FR2295138A1 (fr) Procede de preparation de bis-acetals de p-benzoquinones
BE829355A (fr) Procede de preparation de polysocyanates
FR2277804A1 (fr) Procede de preparation de polyalcools et de leurs ethers et esters
BE831648A (fr) Procede de preparation de noenomycine
BE813169A (fr) Procede de preparation des 3-fluorocephalosporines
BE824612A (fr) Procede de preparation de 3-aminophenols
BE833245A (fr) Procede de preparation de la cefazoline
FR2282429A1 (fr) Procede de preparation de 7b-acylamino-7a-alcoxycephalosporines
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
BE763141A (fr) Procede de preparation de dichloropropanols
FR2289536A1 (fr) Procede de preparation de c
BE831786A (fr) Vaccin contre la gravidite et procede de sa preparation
FR2280375A1 (fr) Procede de preparation de penicilines
BE772448A (fr) Procede de preparation d'un vaccin vivant contre la bursite infectieusedes poules
BE828230A (fr) Procede de preparation de trimethyl-p-benzoquinone
BE824573A (fr) Procede de preparation de la trimethylbenzoquinone
FR2333804A1 (fr) Procede de preparation de derives 3-methylenecepham
FR2292710A1 (fr) Procede de preparation de derives de 7a-methoxycephalosporines
BE821447A (fr) Procede de preparation de trimethyl-p-benzoquinone

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: RESEARCH FOUNDATION FOR NICROBIAL DISEASES OF OSA

Effective date: 19950312